UNICYCIVE THERAPEUTICS, INC. Additional Paid in Capital
UNICYCIVE THERAPEUTICS, INC. (UNCY) had Additional Paid in Capital of $195.63 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2026-08-12
- 2026-06-30: Additional Paid in Capital $195.63M.
- 2026-03-31: Additional Paid in Capital $178.32M.
- 2025-12-31: Additional Paid in Capital $158.00M.
- 2025-09-30: Additional Paid in Capital $150.62M.
| Period end | Additional Paid in Capital | Additional Paid in Capital as first filed |
|---|---|---|
| 2026-06-30 | $195.63M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $178.32M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $158.00M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $150.62M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $123.45M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $111.85M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $108.69M 10-K · filed 2026-03-30 | $108.59M 10-K · filed 2025-03-31 |
| 2024-09-30 | $107.50M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $60.76M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $61.01M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $60.70M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $60.10M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $33.02M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $33.48M 10-Q · filed 2023-05-16 | |
| 2022-12-31 | $33.52M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $33.28M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $33.01M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $32.70M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $32.41M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $32.17M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $3.77M 10-Q · filed 2021-08-16 | |
| 2020-12-31 | $3.24M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |